Submit your research
Start your submission and get more impact for your research by publishing with us.
- Frontiers in Drug Discovery
- Cardiovascular and Hematologic Drugs
Author guidelines
Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.
Editor guidelines
Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.
Peer review
Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.
Publishing fees
Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.
Editors
See allcharles c hong
Michigan State University
East Lansing, United States
Specialty Chief Editor
Cardiovascular and Hematologic Drugs
debabrata chanda
Central Institute of Medicinal and Aromatic Plants, Council of Scientific and Industrial Research (CSIR)
Lucknow, India
Associate Editor
Cardiovascular and Hematologic Drugs
fabian chen
Perelman School of Medicine, University of Pennsylvania
Philadelphia, United States
Associate Editor
Cardiovascular and Hematologic Drugs
michael t. chin
Tufts Medical Center
Boston, United States
Associate Editor
Cardiovascular and Hematologic Drugs
